Silver Book Fact

Undertreatment of patients with sSAS

AS is often undertreated — one study found that 56% of severe symptomatic aortic stenosis (sSAS) patients referred to a cardiothoracic surgeon were not operated on.

Bach D. Prevalence & Characteristics of Unoperated Patients with Severe AS Awareness of HVD The. Journal of Heart Valve Disease. 2011; 20(3). https://experts.umich.edu/en/publications/prevalence-and-characteristics-of-unoperated-patients-with-severe

Reference

Title
Prevalence & Characteristics of Unoperated Patients with Severe AS Awareness of HVD The
Publication
Journal of Heart Valve Disease
Publication Date
2011
Authors
Bach D
Volume & Issue
Volume 20, Issue 3
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence
  • Human Value

Related Facts

  • Survival Rates Over 5 Years for Patients with Medically Managed Severe Aortic Stenosis
     
  • SAS patient hospitalization costs
    Symptomatic aortic stenosis (SAS) patients who do not undergo treatment cost Medicare as much as $1.3 billion each year due to rehospitalization, prolonged stays, admissions to skilled nursing facilities, and…  
  • 1 and 6-month mortality rates without treatment for sSAS
    Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).  
  • 2016 prevalence of Americans 65+ who had AVD
    In 2016, an estimated 5.2 million U.S. adults ages 65+ had aortic valve disease (AVD).   Note: Alliance for Aging Research generated statistic, based on 2005 percentage prevalence estimates by Bach et al. 2007  
  • Prevalence of AS in Americans 75+
    An estimated 12.4%, or ~2.5 million people ages 75+ in North America, have AS.